The oncogenic form of c-ABL, which is a constitutively active fusion protein (BCR-ABL), has been well established in hematopoietic malignancies such as chronic myeloid leukemia 12. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.